<SEC-DOCUMENT>0001213900-16-012164-index.html : 20160331
<SEC-HEADER>0001213900-16-012164.hdr.sgml : 20160331
<ACCEPTANCE-DATETIME>20160331170514
ACCESSION NUMBER:		0001213900-16-012164
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160328
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160331
DATE AS OF CHANGE:		20160331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUCELL CORP /DE/
		CENTRAL INDEX KEY:			0000811641
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				010382980
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12934
		FILM NUMBER:		161543959

	BUSINESS ADDRESS:	
		STREET 1:		56 EVERGREEN DR
		CITY:			PORTLAND
		STATE:			ME
		ZIP:			04103
		BUSINESS PHONE:		2078782770

	MAIL ADDRESS:	
		STREET 1:		56 EVERGREEN DRIVE
		CITY:			PORTLAND
		STATE:			ME
		ZIP:			04103
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k032816_immucellcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k032816_immucellcorp.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f8k032816ex99i_immucell.htm
<DESCRIPTION>CONSTRUCTION LOAN NOTE FOR $2,000,000 EXECUTED BY IMMUCELL CORPORATION IN FAVOR OF TD BANK N.A. DATED MARCH 28, 2016
<TEXT>
Document 2 - file: f8k032816ex99i_immucell.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>f8k032816ex99ii_immucell.htm
<DESCRIPTION>TERM LOAN NOTE FOR $2,500,000 EXECUTED BY IMMUCELL CORPORATION IN FAVOR OF TD BANK N.A. DATED MARCH 28, 2016
<TEXT>
Document 3 - file: f8k032816ex99ii_immucell.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>f8k032816ex99iii_immucell.htm
<DESCRIPTION>SECOND AMENDED AND RESTATED LOAN AGREEMENT (COVENANTS) BETWEEN IMMUCELL CORPORATION AND TD BANK N.A. DATED MARCH 28, 2016
<TEXT>
Document 4 - file: f8k032816ex99iii_immucell.htm

</DOCUMENT>
</SEC-DOCUMENT>